Related Experiment Video
Updated: Aug 30, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
Pilot study of the relationship between histologic progression and hepatic iron concentration in chronic hepatitis C
Anne M Larson1, Shari L Taylor, Donald Bauermeister
1Division of Gastroenterology, University of Washington, Seattle, WA 98195, USA. amlarson@u.washington.edu
Insights
In chronic hepatitis C (HCV), hepatic iron concentration did not increase with disease progression before cirrhosis. However, iron accumulation was observed once cirrhosis developed, suggesting a link that needs further investigation.
Area of Science:
- Hepatology
- Gastroenterology
- Chronic Liver Disease Research
Background:
- Hepatic iron deposition is frequently observed in chronic hepatitis C (HCV) patients.
- Iron overload may contribute to the progression of liver disease in HCV.
- Understanding the interplay between iron and HCV progression is crucial for patient management.
Purpose of the Study:
- To investigate the relationship between hepatic iron concentration (HIC) and histological disease progression in HCV patients.
- To determine if hepatic iron accumulation correlates with worsening liver histology over time.
- To explore the role of iron in the context of cirrhosis development in HCV.
Main Methods:
- Retrospective analysis of 14 HCV patients with two serial liver biopsies before interferon therapy.
- Measurement of hepatic iron concentration (HIC) from liver biopsy samples.
- Assessment of histological parameters including Knodell score, portal inflammation, fibrosis, piecemeal necrosis, and lobular degeneration.
Main Results:
- Histological scores showed significant worsening between biopsies, indicating disease progression (P = 0.007).
- Portal inflammation and fibrosis significantly increased over time (P = 0.028 and P = 0.002, respectively).
- No significant change in HIC was observed in precirrhotic HCV patients, but HIC increased significantly in patients with or progressing to cirrhosis (P = 0.009).
Conclusions:
- Histological progression of HCV in the precirrhotic stage is not associated with increased hepatic iron concentration.
- Hepatic iron accumulation is observed in HCV patients once cirrhosis is present.
- The interaction between HCV progression and hepatic iron deposition warrants further investigation.
Abstract:
Hepatic iron deposition is common in patients with chronic hepatitis C (HCV) and may play a role in progression of liver disease. This pilot study examines the relationship between hepatic iron concentration (HIC) and histologic progression over time in patients with HCV. HIC was retrospectively measured in 14 patients with HCV who had 2 serial liver biopsies prior to the era of interferon therapy. The mean interval between biopsies was 56 +/- 46 months. Mean Knodell score worsened between first and second biopsies (10.0 +/- 2.8 versus 12.4 +/- 3.3; P = 0.007). There was increased portal inflammation (3.2 +/- 0.4 versus 3.6 +/- 0.5; P = 0.028) and fibrosis (1.8 +/- 1.3 versus 2.7 +/- 1.2; P = 0.002), but no significant change in piecemeal necrosis or lobular degeneration. There was no significant change in HIC between first and second biopsy (P = 0.66). However, HIC was noted to increase significantly among patients with cirrhosis on initial biopsy or those who progressed to cirrhosis (P = 0.009). In this pilot study, histologic progression in patients with precirrhotic HCV was not associated with an increase in HIC, whereas hepatic iron accumulation was observed in 3 patients once cirrhosis was present. The interaction between progression of hepatitis C and iron deposition warrants further study.
More Related Videos
07:32Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
Published on: April 12, 2024
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019